Literature DB >> 1577030

Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group.

S Behar1, Z Zahavi, U Goldbourt, H Reicher-Reiss.   

Abstract

The aim of the study was to assess the relationship between paroxysmal atrial fibrillation during acute myocardial infarction and the long-term prognosis of patients after acute myocardial infarction. The incidence of paroxysmal atrial fibrillation among 5803 consecutive hospitalized patients was 9.9% (557/5803). Incidence rose with increasing age (less than or equal to 59 years, 4.2%), (60-69 years, 10.5%), (greater than or equal to 70 years, 16.0%) and was slightly (but not significantly) higher in women (11.0%) than in men (9.6%). The presence of congestive heart failure and mean age represented two major discriminants between patients with paroxysmal atrial fibrillation (70% and 68.6 years) in comparison with their counterparts (35% and 62.3% years). Hospital mortality was significantly higher (25.5%) in patients with paroxysmal atrial fibrillation than in those without (16.2%). However, the effect of paroxysmal atrial fibrillation disappeared when other factors influencing the short term prognosis (i.e. heart failure) were taken into account by a multivariate logistic regression analysis. The covariate adjusted relative odds of in-hospital mortality then fell to 0.82. The 1- and 5-year mortality rates were 18.6% and 43.3% in patients with paroxysmal atrial fibrillation as compared to 8.2% and 25.4% (P less than 0.001), respectively, in patients free of paroxysmal atrial fibrillation. Using a proportional hazards analysis of mortality through the first quarter of 1988 (average follow-up time, 5.5 years) the net risk of dying among patients with paroxysmal atrial fibrillation complicating the acute myocardial infarction is estimated at 1.28 (90% confidence interval, 1.12-1.46) relative to counterparts free of the complication.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1577030     DOI: 10.1093/oxfordjournals.eurheartj.a060046

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

1.  Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.

Authors:  H Nakaya; Y Furusawa; T Ogura; M Tamagawa; H Uemura
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians.

Authors:  Anwar Santoso; Sunu B Raharjo
Journal:  Int J Angiol       Date:  2020-05-06

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 4.  Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Marta Garofoli; Elisa Ramundo; Cristina Poltronieri; Giovanni Mazzotta; Giuseppe Ambrosio; Paolo Verdecchia
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 5.  Atrial Fibrillation Complicating Acute Coronary Syndromes.

Authors:  Sean D Pokorney; Meena Rao; Kent R Nilsson; Jonathan P Piccini
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 6.  Atrial Fibrillation in Acute Coronary Syndrome.

Authors:  Jason C Rubenstein; Michael P Cinquegrani; Jennifer Wright
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 7.  Co-existence of Atrial Fibrillation with Myocardial Infarction - Unhealthy Combination.

Authors:  Maciej Wojcik
Journal:  J Atr Fibrillation       Date:  2012-12-16

8.  Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

Authors:  F Pizzetti; F M Turazza; M G Franzosi; S Barlera; A Ledda; A P Maggioni; L Santoro; G Tognoni
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

9.  Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction.

Authors:  Merih Baykan; Sükrü Celik; Cevdet Erdöl; Ismet Durmuş; Cihan Orem; Mehmet Küçükosmanoğlu; Remzi Yilmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 10.  Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Authors:  Nileshkumar J Patel; Aashay Patel; Kanishk Agnihotri; Dhaval Pau; Samir Patel; Badal Thakkar; Nikhil Nalluri; Deepak Asti; Ritesh Kanotra; Sabeeda Kadavath; Shilpkumar Arora; Nilay Patel; Achint Patel; Azfar Sheikh; Neil Patel; Apurva O Badheka; Abhishek Deshmukh; Hakan Paydak; Juan Viles-Gonzalez
Journal:  World J Cardiol       Date:  2015-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.